Skip to main content
Clinical Trials/ISRCTN65687030
ISRCTN65687030
Completed
Phase 3

A phase III multi-centre randomised controlled trial of low-dose palliative radiotherapy for follicular lymphoma

niversity College London (UK)0 sites548 target enrollmentDecember 1, 2005

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
on-Hodgkin's follicular lymphoma
Sponsor
niversity College London (UK)
Enrollment
548
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2014 results in http://www.ncbi.nlm.nih.gov/pubmed/24572077 2021 5-year follow-up results in https://pubmed.ncbi.nlm.nih.gov/33539729/ (added 05/02/2021)

Registry
who.int
Start Date
December 1, 2005
End Date
September 30, 2011
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity College London (UK)

Eligibility Criteria

Inclusion Criteria

  • The study population will consist of either male or females over the age of 18 years who are diagnosed with histologically proven follicular lymphoma, for whom palliative radiotherapy has been indicated by virture of tumour bulk or anatomical position.

Exclusion Criteria

  • 1\. Stage 1A disease to be treated radically with radiotherapy
  • 2\. Histological sub\-types other than follicular non\-Hodgkin's lymphoma
  • 3\. Predicted prognosis less than 3 months
  • 4\. Chemotherapy within 4 weeks of planned radiotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
A phase III multi-centre randomised controlled trial to assess whether optimal supportive care alone (including dexamethasone) is as effective as optimal supportive care (including dexamethasone) plus whole brain radiotherapy in the treatment of patients with inoperable brain metastases from non-small cell lung canceron-small cell lung cancer with inoperable brain metastasesCancerLung cancer
ISRCTN13826061Medical Research Council (MRC) (UK)534
Completed
Phase 3
A prospective, phase III, controlled, multicentre, randomised clinical trial comparing combination gemcitabine and capecitabine therapy with concurent and sequential chemoimmunotherapy using a telomerase vaccine in locally advanced and metastatic pancreatic cancerocally advanced and metastatic pancreatic cancerCancerLocally advanced and metastatic pancreatic cancer
ISRCTN43482138The University of Liverpool (UK)1,062
Completed
Not Applicable
Mental health intervention for children with epilepsyChildren and young people with common mental health disorders and epilepsyMental and Behavioural Disorders
ISRCTN57823197Great Ormond Street Hospital for Children NHS Foundation Trust334
Completed
Phase 3
Avastin® Randomised Trial with neo-adjuvant chemotherapy for patients with early breast cancerEarly breast cancerCancerMalignant neoplasm of the breast
ISRCTN68502941Cambridge University Hospitals NHS Foundation Trust (UK)800
Completed
Phase 3
IgNiTE: Immunoglobulin in the treatment of encephalitisEncephalitisNervous System DiseasesEncephalitis, myelitis and encephalomyelitis, unspecified
ISRCTN15791925niversity of Oxford18